SEARCH

SEARCH BY CITATION

References

  • 1
    Krivac TC, Rose GS, McBroom JW, Carlson JW, Winter WE, Kost ER. Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease. Obstet Gynaecol Surv 2001;56:56775.
  • 2
    Widrich T, Kennedy AW, Myers TM, Hart WR, Wirth S. Adenocarcinoma in situ of the uterine cervix: management and outcome. Gynaecol Oncol 1996;61:3048.
  • 3
    Farnsworth A, Laverty C, Stoler MH. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 1989;8:32130.
  • 4
    Madelaine MM, Darling JR, Schwartz SM, Shera K, McKnight B, Carter JJ et al. Human papilloma virus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the uterine cervix. Cancer Epidemiol Biomarkers Prev 2001;10:1717.
  • 5
    Muntz HG, Bell DA, Lage JM, Goff BA, Feldman S, Rice LW. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 1992;80:9359.
  • 6
    Hopkins MP, Roberts JA, Schmidt RW. Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:8424.
  • 7
    Houghton SJ, Shafi MI, Rollason TP, Luesley DM. Is loop excision adequate primary management of adenocarcinoma in situ of the cervix? Br J Obstet Gynaecol 1997;104:3259.
  • 8
    Yahya AA, McIndoe GA, Mason WP. Analysis and outcome of 502 cases of laser excision cone (LEC) at the Samaritan Hospital for Women, London. AOJOG 1992;18:3158.
  • 9
    Hopkins M. Adenocarcinoma in situ of the cervix—the margins must be clear. Gynecol Oncol 2000;79:45.
  • 10
    Weisbrot IM, Stabinsky C, Davis AM. Adenocarcinoma in situ of the uterine cervix. Cancer 1972;29:117987.
  • 11
    Qizilbash AH. In-situ and microinvasive adenocarcinoma of the uterine cervix: a clinical, cytologic, and histologic study of 14 cases. J Clin Pathol 1975;64:15570.
  • 12
    Bertrand M, Lickrish GM, Colgan TJ. The anatomic distribution of cervical adenocarcinoma in situ: implications for treatment. Am J Obstet Gynecol 1987;157:215.
  • 13
    Luesley DM, Jordan JA, Woodman CBJ, Watson N, Williams DR, Waddell C. A retrospective review of adenocarcinoma in situ and glandular atypia of the uterine cervix. Br J Obstet Gynaecol 1987;94:699703.
  • 14
    Andersen ES, Arffmann E. Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases. Gynecol Oncol 1989;35:17.
  • 15
    Nicklin JL, Wright RG, Bell JR, Samaratunga H, Cox NC, Ward BG. A clinicopathologic study of adenocarcinoma in situ of the cervix. The influence of cervical HPV infection and other factors, and the role of conservative surgery. Aust NZ Obstet Gynaecol 1991;31:17983.
  • 16
    Cullimore JE, Luesley DM, Rollason TP, Byrne P, Buckley CH, Anderson M et al. A prospective study of conization of cervical intraepithelial glandular neoplasia (CIGN)—a preliminary report. Br J Obstet Gynaecol 1992;99:3148.
  • 17
    Im DD, Duska LA, Rosenshein NB. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995;59:17982.
  • 18
    Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:15864.
  • 19
    Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: the significance of cone biopsy margins. Obstet Gynecol 1996;88:826.
  • 20
    Denehy TR, Gregori CA, Breen J. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997;90:16.
  • 21
    Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol 1998;109:72732.
  • 22
    Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adenocarcinoma in situ of the cervix: management and outcome. Gynecol Oncol 1999;73:34853.
  • 23
    Tay EH, Yew WS, Ho TH. Management of adenocarcinoma in situ (ACIS) of the uteri cervix—a clinical dilemma. Singapore Med J 1999;40:369.
  • 24
    Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Obstet Gynecol 2000;100:2716.
  • 25
    Shin CH, Schorge JO, Lee KR, Sheets EE. Conservative management of adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 2000;69:610.
  • 26
    Lea JS, Shin CH, Sheets EE, Coleman RL, Gehrig PA, Duska LR et al. Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ. Gynecol Oncol 2002;87:12932.
  • 27
    Kennedy AW, Biscotti CV. Further study of the management of cervical adenocarcinoma in situ. Gynecol Oncol 2002;86:3614.
  • 28
    Bryson P, Stulberg R, Shepherd L, McLelland K, Jeffrey J. Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS? Gynecol Oncol 2004;93:4658.
  • 29
    Soutter WP, Haidopoulos D, Gornall RJ, McIndoe GA, Fox J, Mason WP et al. Is conservative treatment for adenocarcinoma in situ of the cervix safe? Br J Obstet Gynaecol 2001;08:11849.
  • 30
    Dalrymple C, Russell P. Thermal artefact after diathermy loop excision and laser excision cone biopsy. Int J Gynae Cancer 1999;9:23842.
  • 31
    Andersen ES, Nielsen K. Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment. Gynecol Oncol 2002;86:3659.